Referensi Nilai Lab Normal (http://rc.gnomio.com)
HEMATOLOGI
| Erythrocyte count | 4.2-5.9 ×106/μL (4.2-5.9 x 1012 cells/L) |
| Erythrocyte sedimentation rate | Male: 0-15 mm/h Female: 0-20 mm/h |
| Erythropoietin | less than 30 mU/mL (30 U/L) |
| Haptoglobin serum | 50-150 mg/dL (500-1500 mg/L) |
| Hematocrit | Male: 41%-51% Female: 36%-47% |
| Hemoglobin, | Male: 14-17 g/dL (140-170 g/L) Female: 12-16 g/dL (120-160 g/L) |
| Mean corpuscular hemoglobin | 28-32 pg |
| Mean corpuscular hemoglobin concentration 32-36 g/dL (320-360 g/L) | 32-36 g/dL (320-360 g/L) |
| Mean corpuscular volume | 80-100 fL |
| Reticulocyte count | 0.5%-1.5% of erythrocytes; absolute: 23,000-90,000 cells/μL (23-90 ×109/L) |
| Leukocyte count | 4000-10,000/μL (4.0-10 ×109/L) |
| Platelet count | 150,000-350,000/μL (150-350 ×109/L) |
| Bleeding time | Less than 10 min |
| Activated partial thromboplastin time | 25-35 s |
| Prothrombin time | 11-13 s |
| D-Dimer | less than 0.5 μg/mL (500 mg/L) |
| Ferritin | 15-200 ng/mL (15-200 mg/L) |
| Iron serum | 60-160 μg/dL (11-29 μmol/L) |
| TIBC | 250-460 μg/dL (45-82 μmol/L) |
| Transferrin saturation | 20%-50% |
BLOOD, PLASMA, AND SERUM CHEMISTRY STUDIES
| Albumin serum | 3.5-5.5 g/dL (35-55 g/L) |
| α-Fetoprotein | 0-20 ng/mL (0-20 μg/L) |
| Aminotransferase, alanine (ALT) / SGPT | 0-35 U/L |
| Aminotransferase, aspartate (AST) / SGOT | 0-35 U/L |
| Ammonia plasma | 40-80 μg/dL (23-47 μmol/L) |
| Amylase, serum | 0-130 U/L |
| Antinuclear antibody | positive: titer > 1:160 |
| Bicarbonate serum | 23-28 meq/L (23-28 mmol/L) |
| Bilirubin serum | Total: 0.3-1.2 mg/dL (5.1-20.5 μmol/L) Direct: 0-0.3 mg/dL (0-5.1 μmol/L) |
| Blood urea nitrogen | 8-20 mg/dL (2.9-7.1 mmol/L) |
| Cholesterol, plasma Total | 150-199 mg/dL (3.88-5.15 mmol/L), desirable |
| Low-density lipoprotein (LDL) | Less than or equal to 130mg/dL (3.36 mmol/L), desirable |
| High-density lipoprotein (HDL) | Greater than or equal to40 mg/dL (1.04 mmol/L), desirable |
| Complement serum C3 | 55-120 mg/dL (550-1200 mg/L) |
| Total (CH50) | 37-55 U/mL (37-55 kU/L) |
| Creatine kinase, serum | 30-170 U/L |
| Creatinine serum | 0.7-1.3 mg/dL (61.9-115 μmol/L) |
| Electrolytes, serum | Sodium 136-145 meq/L (136-145 mmol/L) Potassium 3.5-5.0 meq/L (3.5-5.0 mmol/L) Chloride 98-106 meq/L (98-106 mmol/L) Magnesium 1.5-2.4 mg/dL (0.62-0.99 mmol/L) Phosphorus 3-4.5 mg/dL (0.97-1.45 mmol/L) |
| Fibrinogen, plasma | 150-350 mg/dL (1.5-3.5 g/L) |
| Glucose, plasma | Fasting, 70-100 mg/dL (3.9-5.6 mmol/L) |
| γ-Glutamyltransferase, serum | 0-30 U/L |
| Homocysteine | Male: 4-16 μmol/L female: 3-14 μmol/L |
| Immunoglobulins | IgG: 640-1430 mg/dL (6.4-14.3 g/L) IgA: 70-300 mg/dL (0.7-3.0 g/L) IgM: 20-140 mg/dL (0.2-1.4 g/L) IgD: Less than 8 mg/dL (80 mg/L) IgE: 0.01-0.04 mg/dL (0.1-0.4 mg/L) |
| Lactate dehydrogenase | 60-100 U/L |
| Lactic acid, venous blood | 6-16 mg/dL (0.67-1.8 mmol/L) |
| Lipase, serum | Less than 95 U/L |
| Protein, serum | Total: 6.0-7.8 g/dL (60-78 g/L) Albumin: 3.5-5.5 g/dL (35-55 g/L) Globulins: 2.5-3.5 g/dL (25-35 g/L) |
| Prostate-specific antigen, serum | optimal less than 4 ng/mL |
| Rheumatoid factor | less than 40 U/mL (less than 40 kU/L) |
| Transferrin saturation | 20%-50% |
| Triglycerides | Less than 250 mg/dL (2.82 mmol/L), desirable |
| Troponins, serum | Troponin I: 0-0.5 ng/mL (0-0.5 μg/L) Troponin T:0-0.10 ng/mL (0-0.10 μg/L) |
| Uric acid | 2.5-8 mg/dL (0.15-0.47 mmol/L) |
ENDOCRINE
| Adrenocorticotropin (ACTH) | 9-52 pg/mL (2-11 pmol/L) |
| Aldosterone, serum | Supine - 2-5 ng/dL (55-138 pmol/L) Standing - 7-20 ng/dL (194-554 pmol/L) |
| Aldosterone, urine | 5-19 μg/24 h (13.9-52.6 nmol/24 h) |
| Catecholamines | Epinephrine plasma (supine): less than 75 ng/L (410 pmol/L) Norepinephrine, plasma (supine): 50-440 ng/L (296-2600 pmol/L) |
| Catecholamines, 24-hour, urine | Less than 100 μg/m2per 24 h (591 nmol/m2 per 24 h) |
| Cortisol free, urine | Less than 90 μg/24 h (248 nmol/24 h) |
| Dehydroepiandrosterone sulfate (DHEA), plasma | Male: 1.3-5.5 mg/mL (3.5-14.9 μmol/L) Female: 0.6-3.3 mg/mL (1.6-8.9 μmol/L) |
| Estradiol, serum | Male: 10-30 pg/mL (37-110 pmol/L); Female: day 1-10, 50-100 pmol/L; day 11-20, 50-200 pmol/L; day 21-30, 70-150 pmol/L |
| Follicle-stimulating hormone, serum | Male (adult): 5-15 mU/mL (5-15 U/L) Female: follicular or luteal phase, 5-20 mU/mL (5-20 U/L); midcycle peak, 30-50 mU/mL (30-50 U/L); postmenopausal, greater than 35 mU/mL (35 U/L) |
| Growth hormone, plasma | After oral glucose, less than 2 ng/mL (2 μg/L); response to provocative stimuli: greater than 7 ng/mL (7 μg/L) |
| Luteinizing hormone, serum | Male: 3-15 mU/mL (3-15 U/L) Female: follicular or luteal phase, 5-22 mU/mL (5-22 U/L); midcycle peak, 30-250 mU/mL (30-250 U/L); postmenopausal, greater than 30 mU/mL (30 U/L) |
| Parathyroid hormone, serum | 10-65 pg/mL (10-65 ng/L) |
| Prolactin, serum | Male: less than 15 ng/mL (15 mg/L); Female: less than 20 ng/mL (20 mg/L) |
| Testosterone, serum | Male (adult): 300-1200 ng/dL (10-42 nmol/L) Female: 20-75 ng/dL (0.7-2.6 nmol/L) |
| Thyroid function tests (normal ranges vary) | Thyroid iodine (131I) uptake: 10% to 30% of administered dose at 24 h |
| Thyroid-stimulating hormone (TSH) | 0.5-5.0 μU/mL (0.5-5.0 mU/mL) |
| Thyroxine (T4), serum | Total - 5-12 μg/dL (64-155 nmol/L) Free - 0.9-2.4 ng/dL (12-31 pmol/L) Free T4 index: 4-11 |
| Triiodothyronine, resin (T3) | 25%-35% |
| Triiodothyronine, serum (T3) | 70-195 ng/dL (1.1-3.0 nmol/L) |
| Vanillylmandelic acid, urine | Less than 8 mg/24 h (40.4 μmol/24 h) |
| Vitamin D 1,25-dihydroxy, serum | 25-65 pg/mL (60-156 pmol/L) |
| 25-hydroxy, serum | 15-80 ng/mL (37-200 nmol/L) |
ARTERIAL BLOOD GAS ANALYSIS
| pH | 7.38-7.44 |
| Pco2 | 35-45 mm Hg |
| Po2 | 80-100 mm Hg |
| Oxygen saturation | 95% or greater |
| Bicarbonate | 23-28 meq/L (23-28 mmol/L) |
URINE
| Albumin–creatinine ratio | < 30 mg/g |
| Calcium | 100-300 mg/24 h (2.5-7.5 mmol/24 h) on unrestricted diet |
| Creatinine | 15-25 mg/kg per 24 h (133-221 mmol/kg per 24 h) |
| Creatinine clearance | 90-140 mL/min (0.09-0.14 L/min) |
| 5-Hydroxyindoleacetic acid (5-HIAA) | 2-9 mg/24 h (10.4-46.8 μmol/24 h) |
| Protein–creatinine ratio | < 0.2 mg/mg |
| Sodium | 100-260 meq/24 h (100-260 mmol/24 h) (varies with intake) |
| Uric acid | 250-750 mg/24 h (1.48-4.43 mmol/24 h) (varies with diet) |
| Gastrin, serum | 0-180 pg/mL (0-180 ng/L) |
| Stool fat | Less than 5 g/d on a 100-g fat diet |
| Stool weight | Less than 200 g/d |
PULMONARY
| Forced expiratory volume in 1 second (FEV1) | > 80% predicted |
| Forced vital capacity (FVC) | > 80% predicted |
| FEV1/FVC | Greater than 75% (0.75) |
CEREBROSPINAL FLUID
| Cell count | 0-5 cells/μL (0-5 ×106cells/L) |
| Glucose | 40-80 mg/dL (2.5-4.4 mmol/L); less than 40% of simultaneous plasma concentration is abnormal |
| Pressure (opening) | 70-200 cm H2O |
| Protein | 15-60 mg/dL (150-600 mg/L) |
HEMODYNAMIC MEASUREMENTS
| Cardiac index | 2.5–4.2 L/min/m2 |
| Left ventricular ejection fraction | 45%–70% |
| Pulmonary artery pressure | Systolic: 20–25 mm Hg Diastolic: 5–10 mm Hg Mean: 9–16 mm Hg |
| Pulmonary capillary wedge | 6–12 mm Hg |
| Right atrium | mean 0–5 mm Hg |
| Right ventricle | Systolic: 20–25 mm Hg Diastolic: 0–5 mm Hg |